{"id":"W4416015139","doi":"10.1007/s41669-025-00610-1","title":"Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis","year":2025,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; ABB (Canada); CancerCare Manitoba; University of Calgary","funders":"","keywords":"Venetoclax; Obinutuzumab; Ven; Chronic lymphocytic leukemia; Ibrutinib; Bendamustine; IGHV@; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006300865,0.0003268672,0.0008442981,0.001232364,0.00009887179,0.0001547496,0.0006231207,0.0001459158,0.0005063772],"category_scores_gemma":[0.00005478848,0.0002965009,0.0000724433,0.001960099,0.0001350482,0.0003844309,0.000212315,0.000399074,0.00005026265],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.5178803,"about_ca_system_score_gemma":0.1681979,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7030901,"about_ca_topic_score_gemma":0.7692711,"domain_scores_codex":[0.9974029,0.0001445344,0.0006088414,0.000789143,0.0002100547,0.000844494],"domain_scores_gemma":[0.9984518,0.0001558853,0.0001484844,0.0006676297,0.0001770707,0.0003990785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0100189,0.0002738993,0.7677886,0.0007054936,0.00269251,0.0006476308,0.0008188841,0.2017238,0.00001159302,0.0002155771,0.001773316,0.01332982],"study_design_scores_gemma":[0.1129212,0.0003967126,0.1857493,0.0003476694,0.0008005315,0.0000128954,0.00004723144,0.6959579,0.0003587118,0.00003995048,0.002993342,0.0003745161],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987792,0.0001842092,0.00001685928,0.0001930742,0.00005186817,0.005090973,0.00006017741,0.00002605434,0.006584778],"genre_scores_gemma":[0.9971298,0.0001570731,0.00007185079,0.0006868017,0.00001536883,0.0005939821,0.0004774018,0.00003833489,0.0008293884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5820393,"threshold_uncertainty_score":0.9999487,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01948353024040585,"score_gpt":0.3295830902794832,"score_spread":0.3100995600390773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}